J W Paxton|F J Rowell - JoVE Visualize

Showing results (101-110 of 106) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 106 results.

Research in Veterinary Science|March 1, 1991

Development of an enzyme-linked immunosorbent assay for the detection and measurement of the trypanocidal drug isometamidium chloride in cattleD D Whitelaw, E A Gault, P H Holmes, et al.

European Journal of Clinical Pharmacology|January 1, 1977

Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrationsJ W Paxton, F Rowell, J G Ratcliffe, et al.

Cancer Chemotherapy and Pharmacology|June 15, 1999

Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trialP Kestell, I C Dunlop, M R McCrystal, et al.

Cancer Chemotherapy and Pharmacology|June 15, 1999

Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2001

Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humansS F Zhou, J W Paxton, M D Tingle, et al.

Cancer Research|November 15, 1988

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.

Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 106 results.

Research in Veterinary Science|March 1, 1991

Development of an enzyme-linked immunosorbent assay for the detection and measurement of the trypanocidal drug isometamidium chloride in cattleD D Whitelaw, E A Gault, P H Holmes, et al.

European Journal of Clinical Pharmacology|January 1, 1977

Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrationsJ W Paxton, F Rowell, J G Ratcliffe, et al.

Cancer Chemotherapy and Pharmacology|June 15, 1999

Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trialP Kestell, I C Dunlop, M R McCrystal, et al.

Cancer Chemotherapy and Pharmacology|June 15, 1999

Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2001

Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humansS F Zhou, J W Paxton, M D Tingle, et al.

Cancer Research|November 15, 1988

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.

Pageof 11